Total Payments
$1,581
2024 Payments
$352.81
Companies
22
Transactions
71
Medicare Patients
7,920
Medicare Billing
$822,288
Payment Breakdown by Category
Food & Beverage$1,243 (78.6%)
Other$338.71 (21.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,243 | 67 | 78.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $338.71 | 4 | 21.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Notal Vision, Inc. | $338.71 | 4 | $0 (2022) |
| Shire North American Group Inc | $249.81 | 19 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $151.72 | 7 | $0 (2022) |
| ABBVIE INC. | $117.39 | 4 | $0 (2024) |
| Horizon Therapeutics plc | $85.30 | 5 | $0 (2023) |
| ANI Pharmaceuticals, Inc. | $72.02 | 2 | $0 (2024) |
| Halozyme Inc | $67.95 | 4 | $0 (2020) |
| Amgen Inc. | $59.39 | 3 | $0 (2024) |
| Alcon Laboratories Inc | $58.03 | 2 | $0 (2017) |
| Allergan, Inc. | $56.24 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $352.81 | 14 | ABBVIE INC. ($117.39) |
| 2023 | $58.25 | 3 | Horizon Therapeutics plc ($39.86) |
| 2022 | $444.97 | 10 | Notal Vision, Inc. ($338.71) |
| 2021 | $100.03 | 6 | Novartis Pharmaceuticals Corporation ($37.56) |
| 2020 | $78.78 | 5 | Mallinckrodt Hospital Products Inc. ($51.35) |
| 2019 | $78.17 | 4 | Novartis Pharmaceuticals Corporation ($23.87) |
| 2018 | $192.18 | 9 | Shire North American Group Inc ($76.24) |
| 2017 | $276.12 | 20 | Shire North American Group Inc ($152.44) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/05/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $52.86 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/31/2024 | Alcon Vision LLC | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Ophthalmology | ||||||
| 07/29/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 07/02/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $23.01 | General |
| Category: Corneal Health | ||||||
| 06/17/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/11/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: EYE CARE | ||||||
| 06/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/23/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: EYE CARE | ||||||
| 04/25/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: EYE CARE | ||||||
| 03/04/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/08/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: OPTOMETRY | ||||||
| 01/12/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: EYE CARE | ||||||
| 10/23/2023 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Ophthalmology | ||||||
| 09/13/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: TEPEZZA | ||||||
| 01/20/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: TEPEZZA | ||||||
| 12/29/2022 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/05/2022 | Notal Vision, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $129.61 | General |
| 11/02/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: TEPEZZA | ||||||
| 11/01/2022 | Notal Vision, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $38.08 | General |
| 09/13/2022 | Notal Vision, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $158.22 | General |
| 09/13/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: TEPEZZA | ||||||
| 05/26/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/23/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,870 | 2,923 | $487,805 | $197,158 |
| 2022 | 11 | 1,866 | 2,903 | $444,702 | $197,221 |
| 2021 | 12 | 1,948 | 3,017 | $470,565 | $216,164 |
| 2020 | 15 | 2,236 | 3,033 | $467,756 | $211,746 |
Total Patients
7,920
Total Services
11,876
Medicare Billing
$822,288
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 493 | 1,288 | $153,640 | $86,006 | 56.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 462 | 569 | $79,660 | $52,483 | 65.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 106 | 106 | $22,154 | $11,021 | 49.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 314 | 397 | $65,505 | $10,903 | 16.6% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 31 | 58 | $34,344 | $9,409 | 27.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 141 | 149 | $22,350 | $7,314 | 32.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 22 | 26 | $39,312 | $7,237 | 18.4% |
| 92134 | Imaging of retina | Office | 2023 | 111 | 126 | $20,790 | $3,924 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $4,896 | $2,579 | 52.7% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 11 | 17 | $28,175 | $2,117 | 7.5% |
| 92250 | Photography of the retina | Office | 2023 | 68 | 72 | $8,208 | $2,108 | 25.7% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 18 | 18 | $2,322 | $1,043 | 44.9% |
| 92025 | Ct scan of cornea | Office | 2023 | 12 | 13 | $845.00 | $391.50 | 46.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 41 | 43 | $2,580 | $376.11 | 14.6% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 16 | 17 | $3,024 | $244.45 | 8.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 511 | 1,307 | $130,700 | $87,136 | 66.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 506 | 605 | $84,700 | $53,176 | 62.8% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 114 | 114 | $23,826 | $11,831 | 49.7% |
| 92133 | Imaging of optic nerve | Office | 2022 | 295 | 387 | $63,855 | $10,683 | 16.7% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 44 | 66 | $37,584 | $10,623 | 28.3% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 33 | 34 | $51,408 | $9,110 | 17.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 165 | 179 | $26,850 | $9,103 | 33.9% |
| 92134 | Imaging of retina | Office | 2022 | 73 | 84 | $13,860 | $2,661 | 19.2% |
| 92250 | Photography of the retina | Office | 2022 | 62 | 63 | $7,182 | $1,692 | 23.6% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 13 | 13 | $1,677 | $798.00 | 47.6% |
About Dr. William Smith, MD
Dr. William Smith, MD is a Ophthalmology healthcare provider based in Temecula, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497709349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Smith, MD has received a total of $1,581 in payments from pharmaceutical and medical device companies, with $352.81 received in 2024. These payments were reported across 71 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,243).
As a Medicare-enrolled provider, Smith has provided services to 7,920 Medicare beneficiaries, totaling 11,876 services with total Medicare billing of $822,288. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Temecula, CA
- Active Since 05/22/2006
- Last Updated 05/14/2008
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497709349
Products in Payments
- XIIDRA (Drug) $363.45
- DURYSTA (Drug) $94.09
- TEPEZZA (Drug) $85.30
- PURIFIED CORTROPHIN GEL (Drug) $72.02
- Hylenex (Drug) $67.95
- TEPEZZA (Biological) $59.39
- Centurion (Device) $58.03
- ACTHAR (Biological) $51.35
- LUMIGAN (Drug) $50.64
- TRAVATAN Z (Drug) $47.44
- rocklatan (Drug) $42.17
- TearCare SmartLid (Device) $27.85
- XDEMVY (Drug) $27.23
- VEVYE (Drug) $26.44
- VYZULTA (Drug) $23.27
- CE-marked KXLA system (Device) $23.01
- BROMSITE (Drug) $22.30
- PAZEO (Drug) $22.17
- OXERVATE (Drug) $19.32
- BESIVANCE (Drug) $16.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.